Clinical implications of the non-luminal intrinsic subtypes in hormone receptor-positive breast cancer

Roger R. Gomis; Charles M. Perou; Montserrat Muñoz-Mateu; Aleix Prat; Juan Miguel Cejalvo; Tomás Pascual; Aranzazu Fernández-Martínez; Fara Brasó‐Maristany

doi:10.17615/10bv-y622

Related Publications

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Thérese Sørlie , Charles M. Perou , Robert Tibshirani +14 more

The purpose of this study was to classify breast carcinomas based on variations in gene expression patterns derived from cDNA microarrays and to correlate tumor characteristics ...

2001 Proceedings of the National Academy o... 10782 citations

Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review

Sergiusz Łukasiewicz , Marcin Czeczelewski , Alicja Forma +3 more

Breast cancer (BC) is the most frequently diagnosed cancer in women worldwide with more than 2 million new cases in 2020. Its incidence and death rates have increased over the l...

2021 Cancers 1558 citations

Repeated observation of breast tumor subtypes in independent gene expression data sets

Thérese Sørlie , Robert Tibshirani , Joel S. Parker +13 more

Characteristic patterns of gene expression measured by DNA microarrays have been used to classify tumors into clinically relevant subgroups. In this study, we have refined the p...

2003 Proceedings of the National Academy o... 5372 citations

Alpelisib for <i>PIK3CA</i> -Mutated, Hormone Receptor–Positive Advanced Breast Cancer

Fabrice André , Eva Ciruelos , Gábor Rubovszky +17 more

Treatment with alpelisib-fulvestrant prolonged progression-free survival among patients with <i>PIK3CA</i>-mutated, HR-positive, HER2-negative advanced breast cancer who had rec...

2019 New England Journal of Medicine 2305 citations

Incidence and implications of HER2 and hormonal receptor overexpression in newly diagnosed metastatic breast cancer (MBC)

F Penault–Llorca , Anne Vincent‐Salomon , M-C Mathieu +3 more

764 Background: Overexpression of the HER2 receptor protein predicts a worse prognosis and higher metastatic risk in patients (pts) with breast cancer. HER2 positivity also has ...

2005 Journal of Clinical Oncology 18 citations

Publication Info

Year: 2025
Type: article
Citations: 0
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Clinical implications of the non-luminal intrinsic subtypes in hormone receptor-positive breast cancer

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                    Roger R. Gomis, 
                                
                                    Charles M. Perou, 
                                
                                    Montserrat Muñoz-Mateu
                                
                                et al.
                            
                            (2025). 
                            Clinical implications of the non-luminal intrinsic subtypes in hormone receptor-positive breast cancer. 
                            UNC Libraries
                            
                            .
                            https://doi.org/10.17615/10bv-y622

Identifiers

DOI: 10.17615/10bv-y622